Compare RLAY & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | ARCB |
|---|---|---|
| Founded | 2015 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.1B |
| IPO Year | 2020 | 1994 |
| Metric | RLAY | ARCB |
|---|---|---|
| Price | $18.33 | $130.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | $27.58 | ★ $166.85 |
| AVG Volume (30 Days) | ★ 2.5M | 152.8K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 0.37% |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,355,000.00 | ★ $1,657,864,000.00 |
| Revenue This Year | N/A | $12.44 |
| Revenue Next Year | $60.51 | $7.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 53.44 | 12.56 |
| 52 Week Low | $5.95 | $59.43 |
| 52 Week High | $21.27 | $176.69 |
| Indicator | RLAY | ARCB |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 48.53 |
| Support Level | $17.67 | $124.99 |
| Resistance Level | $20.09 | $135.48 |
| Average True Range (ATR) | 0.97 | 3.69 |
| MACD | 0.10 | 0.40 |
| Stochastic Oscillator | 65.28 | 49.94 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.